Bangkok Dusit Medical Services Public Company Limited (BDMS) continues to advance preventive healthcare initiatives this year through the launch of the “BDMS Preventive Vaccine 2026” campaign under the concept “Strengthening Health, Building Immunity.” The campaign aims to expand access to essential vaccines for people of all ages at reasonable service rates, while driving tangible progress in preventive public healthcare through collaboration between the private healthcare and health insurance sectors.
As Thailand’s largest operator of integrated healthcare services, BDMS has consistently underscored the importance of preventive care. The “BDMS Preventive Vaccine 2026” campaign reflects this commitment by taking a systematic approach to disease prevention, strengthening immunity, reducing health risks, and helping to lower long-term medical costs. At the same time, it reinforces sustainable healthcare practices in alignment with the growing global emphasis on prevention.
The “BDMS Preventive Vaccine 2026” program covers vaccines for two key disease groups, including influenza vaccines priced at THB 500 for the trivalent vaccine and THB 550 for the quadrivalent vaccine as well as the herpes zoster (shingles) vaccine, administered in a two-dose series at a price of THB 11,500. The shingles vaccine has seen increasing demand, particularly among adults who prioritize disease prevention and aim to reduce the risk of long-term complications.
This initiative represents a collaboration between the healthcare and life insurance sectors. Health insurance policyholders are eligible to receive vaccination services under the program from May 1 to May 31, 2026, at participating hospitals within the BDMS network nationwide.
Symbol: BDMS